Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,816 public trials 1,781 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors

NCT03565445

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +27 more
Locations
  • Yale Center for Clinical Investigation New Haven, Connecticut, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Cancer Center at Greater Baltimore Medical Baltimore, Maryland, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 42 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

NCT03800836

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Pacific Shores Medical Group Long Beach, California, United States
  • St Vincents Hospital; Cardiopulmonary transplant Ambulatory Care Dept Darlinghurst, New South Wales, Australia
  • Austin Hospital Heidelberg, Victoria, Australia
  • Peter MacCallum Cancer Center North Melbourne, Victoria, Australia
View all 18 locations
View Trial Details
Completed

Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer

NCT02980341

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Southeastern Regional Medical Center Newnan, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details

Related conditions